Interestingly, a novel alteration was observed in desmoplastic melanomas, consisting of the recurrent (14.5% of cases) promoter mutation of the NFKB Inhibitor Epsilon (NFKBIE) gene, encoding for an inhibitor of NFκB. Here, NFKB1 is linked to melanoma.